Schistosoma Haematobium Infections and Praziquantel

Phase 3 Completed 520 enrolled University of Khartoum Hikma Pharmaceuticals LLC · collab

Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the impact of praziquantel for the treatment of Schistosoma haematobium infection among schoolchildren in Al Salamania in Central Sudan.

Timeline

Start: 2008-08
Primary completion: 2012-08
Completion: 2012-09

Publications

Results Ahmed AM, El Tash LA, Mohamed EY, Adam I. High levels of Schistosoma mansoni infections among schoolchildren in central Sudan one year after treatment with praziquantel. J Helminthol. 2012 Jun;86(2):228-32. doi: 10.1017/S0022149X11000290. Epub 2011 Jun 8.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Praziquantel	Small molecule	40 mg/kg	Oral

Schistosoma Haematobium Infections and Praziquantel

Summary

Timeline

Publications

Drugs

Indications